Evidence map›Paper›PMID 32385601›Full record

ArticleDiabetologia2020

Serine administration as a novel prophylactic approach to reduce the severity of acute pancreatitis during diabetes in mice.

Rong Chen, Thorsten Hornemann, Saša Štefanić, Elisabeth M Schraner, Richard Zuellig, Theresia Reding, Ermanno Malagola, Darren C Henstridge, Andrew P Hills, Rolf Graf and 1 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Article
  3. [Dietary serine supplementation inhibits the hepatic macrophage AKT/mTOR pathway and improves primary biliary cholangitis].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2026
    Article
  4. Exogenous L-Serine AlleviatesVeterinary sciences · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Rong ChenSwiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland.
Thorsten HornemannInstitute for Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0002-4218-1087
Saša ŠtefanićInstitute of Parasitology, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-7367-1831
Elisabeth M SchranerInstitute of Veterinary Anatomy and Virology, University of Zurich, Zurich, Switzerland.ORCID 0000-0003-4608-4812
Richard ZuelligDivision of Endocrinology, Diabetes & Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland.
Theresia RedingSwiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0003-4613-0874
Ermanno MalagolaSwiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-9294-3097
Darren C HenstridgeSchool of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, 7250, Australia.ORCID 0000-0003-4988-767X
Andrew P HillsSchool of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, TAS, 7250, Australia.ORCID 0000-0002-7787-7201
Rolf GrafSwiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland.ORCID 0000-0001-7449-7302
Sabrina SondaSwiss Hepato-Pancreato-Biliary Center, Department of Visceral and Transplantation Surgery, University Hospital Zurich, Zurich, Switzerland. sabrina.sonda@utas.edu.au.ORCID 0000-0001-8152-3425
University of Zurich · CHUniversity of Tasmania · AUUniversity Hospital of Zurich · CH

Funding

Swiss National Science Foundation Grant No. 310030-146725
6 · The paper itself

Abstract

aims/hypothesisCompared with the general population, individuals with diabetes have a higher risk of developing severe acute pancreatitis, a highly debilitating and potentially lethal inflammation of the exocrine pancreas. In this study, we investigated whether 1-deoxysphingolipids, atypical lipids that increase in the circulation following the development of diabetes, exacerbate the severity of pancreatitis in a diabetic setting.

methodsWe analysed whether administration of an L-serine-enriched diet to mouse models of diabetes, an established method for decreasing the synthesis of 1-deoxysphingolipids in vivo, reduced the severity of acute pancreatitis. Furthermore, we elucidated the molecular mechanisms underlying the lipotoxicity exerted by 1-deoxysphingolipids towards rodent pancreatic acinar cells in vitro.

resultsWe demonstrated that L-serine supplementation reduced the damage of acinar tissue resulting from the induction of pancreatitis in diabetic mice (average histological damage score: 1.5 in L-serine-treated mice vs 2.7 in the control group). At the cellular level, we showed that L-serine decreased the production of reactive oxygen species, endoplasmic reticulum stress and cellular apoptosis in acinar tissue. Importantly, these parameters, together with DNA damage, were triggered in acinar cells upon treatment with 1-deoxysphingolipids in vitro, suggesting that these lipids are cytotoxic towards pancreatic acinar cells in a cell-autonomous manner. In search of the initiating events of the observed cytotoxicity, we discovered that 1-deoxysphingolipids induced early mitochondrial dysfunction in acinar cells, characterised by ultrastructural alterations, impaired oxygen consumption rate and reduced ATP synthesis. CONCLUSIONS/

interpretationOur results suggest that 1-deoxysphingolipids directly damage the functionality of pancreatic acinar cells and highlight that an L-serine-enriched diet may be used as a promising prophylactic intervention to reduce the severity of pancreatitis in the context of diabetes.

Indexed as

Acinar CellsAnimalsApoptosisCeruletideDiabetes Mellitus, ExperimentalDisease Models, AnimalDNA DamageEndoplasmic Reticulum StressIn Vitro TechniquesMiceMitochondriaOxygen ConsumptionPancreasPancreatitisReactive Oxygen SpeciesSerine1-deoxysphingolipidCeruletideReactive Oxygen SpeciesSerineSphingolipids1-DeoxysphingolipidsDiabetesL-serineMitochondriaPancreatitis

Identifiers

PMID32385601
OpenAlexW3023656034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.